Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4759805
Max Phase: Preclinical
Molecular Formula: C48H61F3IN7O6S
Molecular Weight: 1048.02
Molecule Type: Unknown
Associated Items:
ID: ALA4759805
Max Phase: Preclinical
Molecular Formula: C48H61F3IN7O6S
Molecular Weight: 1048.02
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCCCNCCCONC(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)C(C)(C)C)cc1
Standard InChI: InChI=1S/C48H61F3IN7O6S/c1-30-43(66-29-55-30)32-16-14-31(15-17-32)27-54-46(63)39-26-34(60)28-59(39)47(64)44(48(2,3)4)57-40(61)13-10-8-6-5-7-9-11-22-53-23-12-24-65-58-45(62)35-19-20-36(49)41(51)42(35)56-38-21-18-33(52)25-37(38)50/h14-21,25,29,34,39,44,53,56,60H,5-13,22-24,26-28H2,1-4H3,(H,54,63)(H,57,61)(H,58,62)/t34-,39+,44-/m1/s1
Standard InChI Key: QYHUXMHVDIGTRN-SVJXQAPASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1048.02 | Molecular Weight (Monoisotopic): 1047.3401 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Hu J,Wei J,Yim H,Wang L,Xie L,Jin MS,Kabir M,Qin L,Chen X,Liu J,Jin J. (2020) Potent and Selective Mitogen-Activated Protein Kinase Kinase 1/2 (MEK1/2) Heterobifunctional Small-molecule Degraders., 63 (24.0): [PMID:33284613] [10.1021/acs.jmedchem.0c01609] |
Source(1):